ACCAHA 2013 Digoxin Guidelines for Heart Failure Guidelines From the ADHERE REGISTRY Use of Digoxin in Contemporary Studies and Registries Digoxin Toxicity as an Ongoing Clinical Challenge Digoxin Toxicity ID: 718702
Download Presentation The PPT/PDF document "Dispelling Myths and Misconceptions" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1Slide2Slide3
Dispelling Myths and MisconceptionsSlide4
ACC/AHA 2013 Digoxin Guidelines for Heart FailureSlide5
Guidelines From the ADHERE REGISTRY Slide6
Use of Digoxin in Contemporary Studies and RegistriesSlide7
Digoxin Toxicity as an
Ongoing Clinical ChallengeSlide8
Digoxin ToxicitySlide9
Digoxin Toxicity
OutcomesSlide10
Understanding the Pharmacology of DigoxinSlide11
Digoxin Laboratory Values
SurveySlide12
Signs of Digoxin ToxicitySlide13Slide14
Treatment OptionsSlide15
Digoxin-specific Antibody FragmentsSlide16
Digoxin-specific Antibody FragmentsSlide17
Acute Life-threatening Digoxin OverdoseSlide18
Digoxin-specific Antibody FragmentsSlide19
Digoxin Toxicity Is Underrecognized! Slide20
Education and PreventionSlide21
Digoxin Dosages and Serum Concentrations
Nontoxic and Toxic Therapeutic RangesSlide22
Key Take-away Points Slide23
SummarySlide24
AbbreviationsSlide25
Abbreviations (cont)Slide26
ReferencesSlide27
References (cont)Slide28
References (cont)Slide29
References (cont)